Primrose Bio

Primrose Bio, established in 2023 through the merger of Pelican Technology Holdings and Primordial Genetics, focuses on developing high-efficiency production systems for complex biologics. We deliver innovative solutions for biotherapeutics, vaccines, and other critical biologics using advanced protein expression and enzyme engineering. Primrose Bio offers radically new products and tools that unlock unexplored possibilities for the discovery, development, and manufacturing of new molecules. Our mission is to enable the development of innovative therapeutics, vaccines, and ingredients to advance global health. Website :- https://www.primrosebio.com/